Healthcare provider profile · identity verified

Robert Eugene Newman, M.D.

Family Practice · WEST UNION, OH · NPI 1154491249

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	356	75
Atorvastatin Calcium	Atorvastatin Calcium	330	86
Furosemide	Furosemide	249	54
Albuterol Sulfate Hfa	Albuterol Sulfate	248	80
Pantoprazole Sodium	Pantoprazole Sodium	247	44
Lisinopril	Lisinopril	227	59
Omeprazole	Omeprazole	225	55
Amlodipine Besylate	Amlodipine Besylate	218	53
Metoprolol Succinate	Metoprolol Succinate	213	50
Gabapentin	Gabapentin	191	30
Losartan Potassium	Losartan Potassium	172	42
Tamsulosin Hcl	Tamsulosin Hcl	171	36
Metformin Hcl	Metformin Hcl	149	43
Duloxetine Hcl	Duloxetine Hcl	142	25
Trazodone Hcl	Trazodone Hcl	132	26
Januvia	Sitagliptin Phosphate	129	25
Rosuvastatin Calcium	Rosuvastatin Calcium	128	36
Eliquis	Apixaban	113	16
Donepezil Hcl	Donepezil Hcl	111	16
Fluticasone Propionate	Fluticasone Propionate	108	40
Potassium Chloride	Potassium Chloride	106	31
Clopidogrel	Clopidogrel Bisulfate	103	25
Ropinirole Hcl	Ropinirole Hcl	101	19
Escitalopram Oxalate	Escitalopram Oxalate	100	24
Montelukast Sodium	Montelukast Sodium	98	30
Ozempic	Semaglutide	97	15
Hydrochlorothiazide	Hydrochlorothiazide	93	28
Jardiance	Empagliflozin	93	18
Meloxicam	Meloxicam	93	26
Tramadol Hcl	Tramadol Hcl	93	12
Sertraline Hcl	Sertraline Hcl	91	20
Metoprolol Tartrate	Metoprolol Tartrate	87	23
Famotidine	Famotidine	86	18
Pioglitazone Hcl	Pioglitazone Hcl	85	24
Spironolactone	Spironolactone	76	18
Xarelto	Rivaroxaban	71	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	70	16
Finasteride	Finasteride	68	15
Quetiapine Fumarate	Quetiapine Fumarate	68	13
Carvedilol	Carvedilol	66	18
Simvastatin	Simvastatin	66	19
Torsemide	Torsemide	64	11
Hydroxyzine Hcl	Hydroxyzine Hcl	63	16
Lorazepam	Lorazepam	61	suppressed
Atenolol	Atenolol	59	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	19
Trulicity	Dulaglutide	59	suppressed
Synthroid	Levothyroxine Sodium	58	14
Methocarbamol	Methocarbamol	57	11
Bupropion Xl	Bupropion Hcl	56	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	54	11
Prednisone	Prednisone	53	27
Tizanidine Hcl	Tizanidine Hcl	53	15
Lovastatin	Lovastatin	52	13
Triamcinolone Acetonide	Triamcinolone Acetonide	52	25
Citalopram Hbr	Citalopram Hydrobromide	51	14
Pravastatin Sodium	Pravastatin Sodium	51	15
Warfarin Sodium	Warfarin Sodium	49	suppressed
Ondansetron Odt	Ondansetron	48	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	48	13
Oxybutynin Chloride	Oxybutynin Chloride	46	suppressed
Allopurinol	Allopurinol	45	11
Buspirone Hcl	Buspirone Hcl	45	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	suppressed
Memantine Hcl	Memantine Hcl	42	suppressed
Irbesartan	Irbesartan	41	suppressed
Humalog Kwikpen U-100	Insulin Lispro	39	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	39	11
Metformin Hcl Er	Metformin Hcl	39	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	suppressed
Diclofenac Sodium	Diclofenac Sodium	38	suppressed
Ezetimibe	Ezetimibe	38	13
Insulin Lispro Kwikpen U-100	Insulin Lispro	38	13
Testosterone Cypionate	Testosterone Cypionate	35	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	34	suppressed
Ibuprofen	Ibuprofen	34	13
Glimepiride	Glimepiride	33	11
Pregabalin	Pregabalin	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Symbicort	Budesonide/Formoterol Fumarate	32	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	11
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Farxiga	Dapagliflozin Propanediol	29	suppressed
Methotrexate	Methotrexate Sodium	29	suppressed
Diazepam	Diazepam	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	19
Glipizide	Glipizide	27	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	27	suppressed
Nitroglycerin	Nitroglycerin	26	16
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Sucralfate	Sucralfate	26	suppressed
Alendronate Sodium	Alendronate Sodium	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Alprazolam	Alprazolam	24	suppressed
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Celecoxib	Celecoxib	24	suppressed
Liothyronine Sodium	Liothyronine Sodium	24	suppressed
Oxycontin	Oxycodone Hcl	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Cephalexin	Cephalexin	22	18
Novolog Flexpen	Insulin Aspart	22	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Cefdinir	Cefdinir	21	18
Meclizine Hcl	Meclizine Hcl	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Dexlansoprazole Dr	Dexlansoprazole	19	suppressed
Doxepin Hcl	Doxepin Hcl	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Colestipol Hcl	Colestipol Hcl	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Promethazine Hcl	Promethazine Hcl	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Ramipril	Ramipril	16	suppressed
Topiramate	Topiramate	16	suppressed
Fluconazole	Fluconazole	15	suppressed
Naproxen	Naproxen	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Aripiprazole	Aripiprazole	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Vilazodone Hcl	Vilazodone Hcl	13	suppressed
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Linzess	Linaclotide	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Phenytoin	Phenytoin	12	suppressed
Risperidone	Risperidone	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Alogliptin	Alogliptin Benzoate	11	suppressed
Baclofen	Baclofen	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Techlite Pen Needle	Pen Needle, Diabetic	11	suppressed
Temazepam	Temazepam	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error